tykhr
sign in
free sign up
Apellis Pharmaceuticals Inc
Biotechnology
Healthcare
APLS
124 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
18.51
52 week high
36.73
high
18.61
52 week low
16.36
low
18.06
growth
-51.12 %
previous Close
18.61
P/E ratio
market cap
4.13 B
div yield
0
usd
Sep 2024
qoq
revenue
197 M
-1.43 %
net incoming
-57.45 M
-52.55 %
eps
0.00 %
-65.14 %
eps surprise
-54.13 %
net profit margin
-29.19 %
-10.00 %
operating incoming
-47.28 M
-60.58 %
net change in cash
36.81 M
7.01 %
cash on hand
397 M
9.81 %
cost of revenue
33.56 M
42.50 %
top